248 related articles for article (PubMed ID: 34962582)
1. Within-patient comparison between [
Mahieu R; Donders DNV; Krijger GC; Ververs FFT; de Roos R; Bemelmans JLMM; van Rooij R; de Bree R; de Keizer B
Eur J Nucl Med Mol Imaging; 2022 May; 49(6):2023-2036. PubMed ID: 34962582
[TBL] [Abstract][Full Text] [Related]
2. Sentinel lymph node detection in thyroid carcinoma using [
de Vries LH; Lodewijk L; Ververs T; Poot AJ; van Rooij R; Brosens LAA; de Krijger RR; Rinkes IHMB; Vriens MR; de Keizer B
Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):512-520. PubMed ID: 37773437
[TBL] [Abstract][Full Text] [Related]
3. Use of
Unkart JT; Wallace AM
J Nucl Med Technol; 2017 Sep; 45(3):181-184. PubMed ID: 28705929
[No Abstract] [Full Text] [Related]
4. Sentinel lymph node detection in oral cancer: a within-patient comparison between [
den Toom IJ; Mahieu R; van Rooij R; van Es RJJ; Hobbelink MGG; Krijger GC; Tijink BM; de Keizer B; de Bree R
Eur J Nucl Med Mol Imaging; 2021 Mar; 48(3):851-858. PubMed ID: 32839855
[TBL] [Abstract][Full Text] [Related]
5. Use of a novel receptor-targeted (CD206) radiotracer, 99mTc-tilmanocept, and SPECT/CT for sentinel lymph node detection in oral cavity squamous cell carcinoma: initial institutional report in an ongoing phase 3 study.
Marcinow AM; Hall N; Byrum E; Teknos TN; Old MO; Agrawal A
JAMA Otolaryngol Head Neck Surg; 2013 Sep; 139(9):895-902. PubMed ID: 24051744
[TBL] [Abstract][Full Text] [Related]
6.
Murphy BL; Woodwick AR; Murphy KM; Chandler KJ; Johnson GB; Hunt CH; Peller P; Jakub JW; Homb AC
J Nucl Med Technol; 2019 Dec; 47(4):300-304. PubMed ID: 31019032
[TBL] [Abstract][Full Text] [Related]
7. [(99m)Tc]Tilmanocept Accurately Detects Sentinel Lymph Nodes and Predicts Node Pathology Status in Patients with Oral Squamous Cell Carcinoma of the Head and Neck: Results of a Phase III Multi-institutional Trial.
Agrawal A; Civantos FJ; Brumund KT; Chepeha DB; Hall NC; Carroll WR; Smith RB; Zitsch RP; Lee WT; Shnayder Y; Cognetti DM; Pitman KT; King DW; Christman LA; Lai SY
Ann Surg Oncol; 2015 Oct; 22(11):3708-15. PubMed ID: 25670018
[TBL] [Abstract][Full Text] [Related]
8. Lymphoscintigraphy Using Tilmanocept Detects Multiple Sentinel Lymph Nodes in Melanoma Patients.
Balkin DM; Tranah GJ; Wang F; O'Donoghue C; Morell EA; Porubsky C; Nosrati M; Vaquero EM; Kim H; Carr MJ; Montilla-Soler JL; Wu MC; Torre DM; Kashani-Sabet M; Zager JS; Leong SP
Cancer Control; 2023; 30():10732748231153775. PubMed ID: 36705261
[TBL] [Abstract][Full Text] [Related]
9. Perioperative PET/CT lymphoscintigraphy and fluorescent real-time imaging for sentinel lymph node mapping in early staged colon cancer.
Ankersmit M; Hoekstra OS; van Lingen A; Bloemena E; Jacobs MAJM; Vugts DJ; Bonjer HJ; van Dongen GAMS; Meijerink WJHJ
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1495-1505. PubMed ID: 30798428
[TBL] [Abstract][Full Text] [Related]
10. A phase 2 study of (99m)Tc-tilmanocept in the detection of sentinel lymph nodes in melanoma and breast cancer.
Leong SP; Kim J; Ross M; Faries M; Scoggins CR; Metz WL; Cope FO; Orahood RC
Ann Surg Oncol; 2011 Apr; 18(4):961-9. PubMed ID: 21331809
[TBL] [Abstract][Full Text] [Related]
11. Concomitant radio- and fluorescence-guided sentinel lymph node biopsy in squamous cell carcinoma of the oral cavity using ICG-(99m)Tc-nanocolloid.
van den Berg NS; Brouwer OR; Klop WM; Karakullukcu B; Zuur CL; Tan IB; Balm AJ; van den Brekel MW; Valdés Olmos RA; van Leeuwen FW
Eur J Nucl Med Mol Imaging; 2012 Jul; 39(7):1128-36. PubMed ID: 22526966
[TBL] [Abstract][Full Text] [Related]
12. Sentinel Lymph Node Biopsy in Breast Cancer with
Vidal-Sicart S; Rioja ME; Prieto A; Goñi E; Gómez I; Albala MD; Lumbreras L; León LF; Gómez JR; Campos F
J Nucl Med; 2021 May; 62(5):620-627. PubMed ID: 33037087
[No Abstract] [Full Text] [Related]
13. Molecular Imaging of endometrial sentinel lymph nodes utilizing fluorescent-labeled Tilmanocept during robotic-assisted surgery in a porcine model.
Anderson KM; Barback CV; Qin Z; Hall DJ; Hoh CK; Vera DR; McHale MT
PLoS One; 2018; 13(7):e0197842. PubMed ID: 29965996
[TBL] [Abstract][Full Text] [Related]
14. Combined analysis of phase III trials evaluating [⁹⁹mTc]tilmanocept and vital blue dye for identification of sentinel lymph nodes in clinically node-negative cutaneous melanoma.
Sondak VK; King DW; Zager JS; Schneebaum S; Kim J; Leong SP; Faries MB; Averbook BJ; Martinez SR; Puleo CA; Messina JL; Christman L; Wallace AM
Ann Surg Oncol; 2013 Feb; 20(2):680-8. PubMed ID: 23054107
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of "one-day" vs "two-day" injection protocols using Tc-99m tilmanocept for sentinel lymph node biopsy in breast cancer.
Unkart JT; Proudfoot J; Wallace AM
Breast J; 2018 Jul; 24(4):526-530. PubMed ID: 29498443
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node detection in thyroid carcinoma using
de Vries LH; Lodewijk L; de Keizer B; Borel Rinkes IH; Vriens MR
Future Oncol; 2022 Oct; 18(31):3493-3499. PubMed ID: 36069284
[TBL] [Abstract][Full Text] [Related]
17. Tilmanocept as a novel tracer for lymphatic mapping and sentinel lymph node biopsy in melanoma and oral cancer.
Mwagiru D; Shivashankar P; Wong E; Farlow D; Cambden B; Abdul-Razak M
ANZ J Surg; 2022 Oct; 92(10):2607-2612. PubMed ID: 35848587
[TBL] [Abstract][Full Text] [Related]
18. Comparison of [
Ooms M; von Mallek D; Kaiser HJ; Hölzle F; Mottaghy FM; Modabber A
Eur J Nucl Med Mol Imaging; 2023 Feb; 50(3):870-880. PubMed ID: 36305908
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of [(99m)tc]tilmanocept for sentinel lymph node mapping in breast cancer patients: results of two phase 3 trials.
Wallace AM; Han LK; Povoski SP; Deck K; Schneebaum S; Hall NC; Hoh CK; Limmer KK; Krontiras H; Frazier TG; Cox C; Avisar E; Faries M; King DW; Christman L; Vera DR
Ann Surg Oncol; 2013 Aug; 20(8):2590-9. PubMed ID: 23504141
[TBL] [Abstract][Full Text] [Related]
20. Does
Rietbergen DD; Pereira Arias-Bouda LM; van der Hage J; Valdés Olmos RA
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2021; 40(5):275-280. PubMed ID: 34425967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
